Circulating tumor DNA.

Might sound fancy, but this practical analysis reports it is the most cost effective strategy, many times over might we add, for post-treatment surveillance of HPV+ oropharyngeal cancer. | Kowalchuk, JAMA Netw Open 2022

Comments

Popular Posts